ZFIN ID: ZDB-FISH-200302-1
Fish name: gldcudm301/udm301
Genotype: gldcudm301/udm301
Targeting Reagent: none
HUMAN DISEASE MODELED by gldcudm301/udm301
Human Disease Conditions Citations
glycine encephalopathy standard conditions Riché et al., 2018
GENE EXPRESSION
Gene expression in gldcudm301/udm301
RNA expression
Expressed Gene Structure Conditions Figures
gldc standard conditions Fig. 2 from Riché et al., 2018
Reporter gene expression No data available
PHENOTYPE
Phenotype in gldcudm301/udm301
Phenotype Conditions Figures
brain morphology, normal standard conditions Fig. 3 from Riché et al., 2018
brain central nervous system projection neuron axonogenesis normal occurrence, normal standard conditions Fig. 6 from Riché et al., 2018
brain dopaminergic neuron differentiation normal occurrence, normal standard conditions Fig. 6 from Riché et al., 2018
brain neural precursor cell proliferation decreased occurrence, abnormal standard conditions Fig. 6 from Riché et al., 2018
brain neural precursor cell proliferation normal occurrence, normal standard conditions Fig. 6 from Riché et al., 2018
cerebellum has normal numbers of parts of type Purkinje cell, normal standard conditions Fig. 6 from Riché et al., 2018
cerebellum development normal occurrence, normal standard conditions Fig. 6 from Riché et al., 2018
eye far from eye, normal standard conditions Fig. 3 from Riché et al., 2018
eye normal diameter, normal standard conditions Fig. 3 from Riché et al., 2018
musculoskeletal movement decreased occurrence, abnormal chemical treatment by environment: dextromethorphan Fig. 7 from Riché et al., 2018
musculoskeletal movement decreased occurrence, abnormal standard conditions Fig. 3Fig. 7 from Riché et al., 2018
swimming decreased occurrence, abnormal standard conditions Fig. 3Fig. 7 from Riché et al., 2018
swimming occurrence, ameliorated chemical treatment by environment: strychnine Fig. 7 from Riché et al., 2018
swimming occurrence, ameliorated chemical treatment by environment: dextromethorphan Fig. 7 from Riché et al., 2018
whole organism dead, abnormal standard conditions Fig. 3 from Riché et al., 2018
whole organism gldc expression decreased amount, abnormal standard conditions Fig. 2 from Riché et al., 2018
whole organism normal length, normal standard conditions Fig. 3 from Riché et al., 2018
whole organism semi-viable, abnormal standard conditions Fig. 3 from Riché et al., 2018
whole organism arginine increased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism arginine normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism cystathionine increased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism cystathionine normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism dopamine normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism folates normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism gamma-aminobutyric acid decreased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism gamma-aminobutyric acid normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism glutamate(1-) decreased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism glutamate(1-) normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism glycine increased amount, abnormal standard conditions Fig. 2Fig. 4 from Riché et al., 2018
whole organism lactate increased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism lactate normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism leucine increased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism leucine normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism proline increased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism proline normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism sarcosine increased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism serotonin normal amount, normal standard conditions Fig. 4 from Riché et al., 2018
whole organism valine increased amount, abnormal standard conditions Fig. 4 from Riché et al., 2018
whole organism valine normal amount, normal standard conditions Fig. 4 from Riché et al., 2018

CITATIONS  (1)